Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Webster Stephen W Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2023 4 Webster Stephen W (Director) has filed a Form 4 on Cullinan Oncology, Inc.
Txns: Granted 18,450 options to buy @ $13, valued at $239.9k
06/01/2023 4 Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Disposed/sold 16,800 options to buy @ $0.97, valued at $16.3k
Disposed/sold 12,100 options to buy @ $31.83, valued at $385.1k
Disposed/sold 12,100 options to buy @ $5.21, valued at $63k
Disposed/sold 10,482 options to buy @ $9.54, valued at $100k
12/19/2022 4 Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 16,800 options to buy @ $0.97, valued at $16.3k
08/04/2022 4 Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Sold 7,826 shares @ $0.19, valued at $1.5k
06/24/2022 4 Webster Stephen W (Director) has filed a Form 4 on NextCure, Inc.
Txns: Granted 14,250 options to buy @ $4.77, valued at $68k
06/23/2022 4 Webster Stephen W (Director) has filed a Form 4 on Cullinan Oncology, Inc.
Txns: Granted 16,475 options to buy @ $12.73, valued at $209.7k
03/25/2022 4 Webster Stephen W (Director) has filed a Form 4 on Cullinan Oncology, Inc.
Txns: Granted 7,800 options to buy @ $28.8, valued at $224.6k
12/10/2021 4 Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 12,100 options to buy @ $5.21, valued at $63k
08/04/2021 4 Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Sold 777 shares @ $1.2, valued at $932.4
07/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/28/2021 4 Webster Stephen W (Director) has filed a Form 4 on NextCure, Inc.
Txns: Granted 14,250 options to buy @ $8.21, valued at $117k
12/11/2020 4 Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 12,100 options to buy @ $31.83, valued at $385.1k
07/31/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2020 4 Webster Stephen W (Director) has filed a Form 4 on NextCure, Inc.
Txns: Granted 14,250 options to buy @ $24.13, valued at $343.9k
05/04/2020 4 Webster Stephen W (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 10,482 options to buy @ $9.54, valued at $100k
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/17/2019 4 Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Unknown transaction of 6,102 shares @ $114.5, valued at $698.7k
Disposed/sold 35,000 options to buy @ $42.73, valued at $1.5M
Disposed/sold 28,000 options to buy @ $50.55, valued at $1.4M
Disposed/sold 25,000 options to buy @ $56.17, valued at $1.4M
Disposed/sold 55,000 options to buy @ $40.44, valued at $2.2M
Disposed/sold 60,000 options to buy @ $68.45, valued at $4.1M
Disposed/sold 106,015 options to buy @ $3.45, valued at $365.8k
Disposed/sold 19,500 restricted stock units @ $0
08/01/2019 4 Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Granted 35,000 options @ $0
06/17/2019 4 Webster Stephen W (Director) has filed a Form 4 on NextCure, Inc.
Txns: Granted 22,000 options to buy @ $15.57, valued at $342.5k
01/23/2019 4 Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Paid exercise price by delivering 634 shares @ $45.08, valued at $28.6k
Paid exercise price by delivering 629 shares @ $45.08, valued at $28.4k
Exercised 1,750 restricted stock units @ $0
Exercised 2,000 restricted stock units @ $0
01/17/2019 4 Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Granted 35,000 options to buy @ $42.73, valued at $1.5M
Granted 10,000 restricted stock units @ $0
01/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/31/2018 4 Webster Stephen W (Director) has filed a Form 4 on Viking Therapeutics, Inc.
Txns: Bought 8,000 shares @ $5.214, valued at $41.7k
05/23/2018 4 Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Bought 8,000 shares @ $4.59, valued at $36.7k
05/04/2018 4 Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Granted 29,000 options @ $0
01/22/2018 4 Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Paid exercise price by delivering 635 shares @ $50.55, valued at $32.1k
Granted 28,000 options to buy @ $50.55, valued at $1.4M
Granted 8,000 restricted stock units @ $0
Exercised 1,750 restricted stock units @ $0
01/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/20/2017 4 Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Sold 10,000 shares @ $70.14, valued at $701.4k
Exercised 10,000 options to buy @ $3.45, valued at $34.5k
09/19/2017 4 Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics plc
Txns: Granted 10,100 options @ $0
08/15/2017 4 Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Sold 10,000 shares @ $79.38, valued at $793.8k
Exercised 10,000 options to buy @ $3.45, valued at $34.5k
08/02/2017 4 Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Sold 2,337 shares @ $71.12, valued at $166.2k
Exercised 2,337 options to buy @ $3.45, valued at $8.1k
06/27/2017 4 Webster Stephen W (Director) has filed a Form 4 on Nabriva Therapeutics Plc
Txns: Acquired 20,200 options @ $0
Acquired 10,100 options @ $0
06/21/2017 4 Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.
Txns: Sold 7,663 shares @ $60, valued at $459.8k
Exercised 7,663 options to buy @ $3.45, valued at $26.4k
04/26/2017 4 Webster Stephen W (CFO) has filed a Form 4 on Spark Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy